Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
letter
. 2008 Mar;14(3):514–515. doi: 10.3201/eid1403.070473

Dengue Virus, Nepal

Basu Dev Pandey *,, Kouichi Morita , Santa Raj Khanal , Tomohiko Takasaki §, Isao Miyazaki , Tetsuro Ogawa , Shingo Inoue , Ichiro Kurane
PMCID: PMC2570825  PMID: 18325280

To the Editor: Dengue virus belongs to the genus Flavivirus, family Flaviviridae. It has 4 serotypes: dengue virus type 1 (DENV-1), dengue virus type 2 (DENV-2), dengue virus type 3 (DENV-3), and dengue virus type 4 (DENV-4). Dengue virus is maintained in a cycle between humans and Aedes aegypti, domestic day-biting mosquitoes. Dengue virus induces clinical illness, which ranges from a nonspecific viral syndrome (dengue fever [DF]) to severe and fatal hemorrhagic disease (dengue hemorrhagic fever [DHF]). DF/DHF occurs primarily in tropical and subtropical areas of the world. Domestic dengue virus infection occurs in >100 countries; >2.5 billion persons live in these areas. Approximately 100 million cases of DF, 500,000 cases of DHF, and several thousand deaths occur annually worldwide (1). During the past decades, dengue virus has emerged in southern Asia; DF/DHF epidemics have occurred in Bhutan, India, Maldives, Bangladesh, and Pakistan (24).

From August through November 2006, the number of febrile patients increased in 4 major hospitals in the Terai region of Nepal: Nepalgunj Medical College, Bheri Zonal Hospital in Nepalgunj, Tribhuban Hospital in Dang, and Narayani subregional hospital in Birgunj. Patients with severe symptoms were referred to Sukraraj Tropical and Infectious Disease Hospital, Kathmandu, for diagnosis and treatment. The clinical features in most patients were consistent with signs of DF, but some patients showed signs (high fever, rash, ecchymosis, epistaxis, positive tourniquet test, liver dysfunction, and thrombocytopenia [platelet count <100,000/mm3]) consistent with the World Health Organization (WHO) definition of DHF. Ascites and plural effusion developed in 2 patients. Blood specimens were collected from all patients at the time of admission to the local hospitals. Particle agglutination (PA) assay (Pentax Ltd, Tokyo, Japan) (5) and immunoglobulin (Ig) M–capture ELISA (Dengue/JE IgM Combo ELISA kit, Panbio Ltd, Brisbane, Queensland, Australia) were performed. Dengue virus–specific IgM was detected in 11 patients who had fever, headache, and rash (Table). Each of these patients had negative results for Japanese encephalitis virus–specific IgM. Of the 11 patients, 10 had no history of travel to India or other dengue-endemic countries. DF or DHF was initially diagnosed for 7 patients, and viral encephalitis, typhoid fever, or viral fever was diagnosed for others without serologic tests. Reverse transcription–PCR and virus isolation were performed at Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan, but the dengue virus genome was not detected, and no virus was isolated, likely because sample collection was delayed and the sample was transported to Japan in a deteriorated condition.


Table. Clinical and laboratory data for 11 patients admitted to hospitals and diagnosed with dengue fever or dengue hemorrhagic fever, Nepal, 2006*.

Patient age, y/Sex Month admitted Location Initial 
diagnosis Travel history Clinical signs and symptoms Selected laboratory and other test results
20/M Sep Kathmandu DF Yes Fever, headache, nausea Hb 15.4 g/dL; TLC 10,500/mm3; 
Plt 185,000/mm3; blood culture for salmonellae negative; ALT 38 IU/L
27/F Sep Bardiya Viral fever No Fever, headache, vomiting TLC 5,600/mm3; blood culture for salmonellae negative
3/M Sep Salayan Encephalitis No Fever, vomiting, convulsions Widal negative; TLC 4,700/mm3
13/M Oct Sindhuli Typhoid fever No Fever, headache Widal negative; TLC 4,500/mm3; blood culture for salmonellae negative; Brucella antigen negative; chest radiograph normal
22/M Oct Birgunj DHF No Fever, headache, vomiting, ascites Bil 0.8 mg/dL; ALT 80 IU/L; Plt 22,000/mm3; chest radiograph normal
55/F Oct Dang DF No Fever, headache, muscular pain Plt 51,000/mm3; TLC 7,600/mm3; MP negative; ESR 20 mm/h; Bil 0.7 mg/dL
22/F Oct Birgunj Viral fever No Fever, headache, 
body ache Brucella negative; Widal negative; 
TLC 5,600/mm3
13/M Nov Dang DF No Fever, headache, rashes Plt 95,000/mm3; TLC 4,700/mm3; 
Hb 13.1 g%; Bil 0.8mg/dL; ALT 26 IU/L
35/F Nov Birgunj DHF No Fever, headache, bruises; tourniquet: positive Bil 0.81mg/dL; Plt 31,000/mm3; 
PT 2 min 30 s (control 14)
40/M Nov Birgunj DF No Fever, headache, rashes ALT 127IU/L; Plt 110,000 /mm3; 
PCV 38.8%;TLC 5,500/mm3; ultrasonography liver size, 16.8 cm
42/M Nov Dang DF No Fever, headache, rashes Bil 0.7 mg/dL; Widal test negative; 
TLC 6,800/mm3; Plt 164,000/mm3

*Blood specimens were collected at time of hospital admission. Diagnosis was confirmed by using immunoglobulin M–capture ELISA. DF, dengue fever; Hb, hemoglobulin;TLC, total leukocyte count; Plt, platelets; ALT, alanine aminotransferase; DHF, dengue hemorrhagic fever Bil, bilirubin; MP, malaria parasites; ESR, erythrocyte sedimentation rate; PT, prothrombin time; PCV, packed cell volume.

DF/DHF have been considered to be a possible public health threat to Nepal because DF/DHF epidemics have occurred recently in India and Pakistan, which reported several thousand cases and >100 deaths (6). The first DF case in Nepal was reported in 2004 (7). Further, the first DENV-2 strain of Nepal origin was isolated from a Japanese traveler who visited Nepal and in which DF developed after the patient returned to Japan. The isolated DENV-2 (GenBank accession no. AB194882) was 98% homologous with DENV-2 isolated in India (8). The prevalence of dengue virus antibody was reported to be 10.4% in the southwestern region of Nepal (9). These reports suggest that dengue virus has been circulating in Nepal for several years. Thus, DF/DHF has likely been misdiagnosed and illness caused by dengue virus underestimated in Nepal. In contrast, Japanese encephalitis has been a public health problem in southwestern region of Nepal, and large epidemics have occurred almost every year since 1978 (10). Nepal has no dengue surveillance programs, and health professionals do not usually consider dengue as a differential diagnosis.

The emergence occurred in the lowland Terai belt region, which borders the state of Bihar, India. The Aedes mosquito is known to persist in this region. The emerging DENV-2 is likely to have been introduced into Nepal from India.

Footnotes

Suggested citation for this article: Pandey BD, Morita K, Khanal SR, Takasaki T, Miyazaki I, Ogawa T, et al. Dengue virus, Nepal. Emerg Infect Dis [serial on the Internet]. 2008 March [date cited]. Available from http://www.cdc.gov/EID/content/14/3/514.htm

References

  • 1.World Health Organization. Dengue and dengue haemorrhagic fever. Fact sheet no.117; revised 2002. Apr [cited 2006 Oct 31]. Available from http://www.who.int/mediacentre/factsheets/ fs117/en
  • 2.World Health Organization. Dengue outbreak in Bhutan. Communicable Disease Newsletter. 2007;4(1). [Google Scholar]
  • 3.Islam MA, Ahmed M, Begum N, Choudhury N, Khan A, Parquet C, et al. Molecular characterization and clinical evaluation of dengue outbreak in 2002 in Bangladesh. Jpn J Infect Dis. 2006;59:85–91. [PubMed] [Google Scholar]
  • 4.Jamil B, Hasan R, Zafar A, Bewley K, Chamberlain J, Mioulet V, et al. Dengue virus serotype, Karachi, Pakistan. Emerg Infect Dis. 2007;13:182-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Pandey B, Yamamoto A, Morita K, Kurosawa Y, Rai S, Adhikari S, et al. Serodiagnosis of Japanese encephalitis among Nepalese patients by the particle agglutination assay. Epidemiol Infect. 2003;131:881–5 . 10.1017/S0950268803008835 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Gupta E, Dar L, Kapoor G, Broor S. The changing epidemiology of dengue in Delhi. Virol J. 2006;3:92. 10.1186/1743-422X-3-92 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Pandey BD, Rai SK, Morita K, Kurane I. First case of dengue in Nepal. Nepal Med Coll J. 2004;6:157–9. [PubMed] [Google Scholar]
  • 8.Takasaki T, Kotaki A, Nishimura K, Sato Y , Tokuda A, Lim C, et al. Dengue virus type 2 from an imported dengue patient in Japan. First isolation of dengue virus from Nepal. J Travel Med. 2007;14:445–8 [DOI] [PubMed] [Google Scholar]
  • 9.Sherchand JB, Pandey BD, Haruki K, Jimba M. Sero-diagnosis of Japanese encephalitis and dengue virus infection from clinically suspected patients of Nepal. J Inst Med. 2001;23:25–31. [Google Scholar]
  • 10.Epidemiology and Disease Control Division, Ministry of Health Nepal. The annual report of malaria, Kala-azar and Japanese encephalitis in Nepal, 2005. Kathmandu, Nepal: Ministry of Health; 2006.

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES